Related references
Note: Only part of the references are listed.Peptide prodrugs: Improved oral absorption of lopinavir, a HIV protease inhibitor
Sheetal Agarwal et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Bifunctional molecules evade cytochrome P(450) metabolism by forming protective complexes with FK506-binding protein
Paul S. Marinec et al.
MOLECULAR BIOSYSTEMS (2008)
HIV drug development: the next 25 years
Charles Flexner
NATURE REVIEWS DRUG DISCOVERY (2007)
A directed approach for engineering conditional protein stability using biologically silent small molecules
Lystranne A. Maynard-Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Rescue of degradation-prone mutants of the FK506-rapamycin binding (FRB) protein with chemical ligands
Kryn Stankunas et al.
CHEMBIOCHEM (2007)
Chemical control over protein-protein interactions: Beyond inhibitors
Jason E. Gestwicki et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2007)
Fosamprenavir - Clinical pharmacokinetics and drug interactions of the amprenavir prodrug
MB Wire et al.
CLINICAL PHARMACOKINETICS (2006)
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor
DLNG Surleraux et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Highly active antiretroviral therapy: Current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome
G Barbaro et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Preclinical pharmacology and pharmacokinetics of GW433908, a water-soluble prodrug of the human immunodeficiency virus protease inhibitor amprenavir
ES Furfine et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Water-soluble prodrugs of dipeptide HIV protease inhibitors based on O→N intramolecular acyl migration:: design, synthesis and kinetic study
Y Hamada et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay
S Gunaseelan et al.
BIOCONJUGATE CHEMISTRY (2004)
Harnessing chaperones to generate small-molecule inhibitors of amyloid β aggregation
JE Gestwicki et al.
SCIENCE (2004)
Novel bis-tetrahydrofuranylurethane-containin nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro
Y Koh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Conditional protein alleles using knockin mice and a chemical inducer of dimerization
K Stankunas et al.
MOLECULAR CELL (2003)
Peptidylprolyl cis/trans isomerases (immunophilins): Biological diversity targets - Functions
A Galat
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2003)
Prodrugs of HIV protease inhibitors
P Vierling et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Transepithelial transport of prodrugs of the HIV protease inhibitors saquinavir, indinavir, and nelfinavir across Caco-2 cell monolayers
M Rouquayrol et al.
PHARMACEUTICAL RESEARCH (2002)
Design, synthesis, and biological evaluation of anti-HIV double-drugs: Conjugates of HIV protease inhibitors with a reverse transcriptase inhibitor through spontaneously cleavable linkers
H Matsumoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2001)
Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition
GK Dresser et al.
CLINICAL PHARMACOKINETICS (2000)
Share Paper
